Loading...
Denosumab for Management of Parathyroid Carcinoma-Mediated Hypercalcemia
CONTEXT: Most of the morbidity and mortality from parathyroid cancer is due to PTH-mediated hypercalcemia. Classically, management mainly consists of surgical resection, chemotherapy, and alleviation of hypercalcemia using bisphosphonates and calcium receptor agonists. The use of denosumab in the tr...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Endocrine Society
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3913820/ https://ncbi.nlm.nih.gov/pubmed/24178790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-3031 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|